MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 13.11.2025
Oramed Pharmaceuticals Anteile 2011-2026 | ORMP
Anteile Jährlich Oramed Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.3 M | 39 M | 28.5 M | 23.2 M | 17.5 M | 14.9 M | 13.3 M | 12.6 M | 10.8 M | 9.24 M | 7.21 M | 5.88 M | 5.42 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 40.3 M | 5.42 M | 17.5 M |
Anteile Vierteljährlich Oramed Pharmaceuticals
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.8 M | 41.7 M | 41.2 M | 39.9 M | 40.9 M | 41 M | 40.8 M | 40.3 M | 40.4 M | 40.2 M | 40 M | 39.6 M | 39.1 M | 38.8 M | 38.7 M | 38.2 M | 34.5 M | 30.7 M | 28 M | 24.4 M | 19.5 M | 23.2 M | 23.7 M | 17.5 M | 17.5 M | 17.5 M | 17.5 M | 17.4 M | 14.4 M | 14.5 M | 17.4 M | 14.2 M | 13.3 M | 13.3 M | 14.2 M | 13.2 M | 12.5 M | 13.1 M | 13.2 M | 11.6 M | 10.6 M | 10.8 M | 11.6 M | 10.1 M | 8.99 M | 9.89 M | 10.1 M | 7.94 M | 7.09 M | 7.22 M | 7.94 M | 6.83 M | 5.85 M | 5.86 M | 5.85 M | 70.1 M | 70.1 M | 70.1 M | 70.1 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 70.1 M | 5.85 M | 25.2 M |
Anteile anderer Aktien in der Pharmaeinzelhändler
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M |  USA |
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
ANI Pharmaceuticals
ANIP
|
19.3 M | $ 80.97 | 0.78 % | $ 1.56 B | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.21 B | - | -15.15 % | $ 60.3 M |  Britain |
 |
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | USA |
 |
Amarin Corporation plc
AMRN
|
408 M | $ 14.8 | 0.34 % | $ 6.03 B |  Irlanda |
 |
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M |  Canada |
 |
I-Mab
IMAB
|
187 M | - | - | $ 866 M |  China |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | USA |
 |
Aptorum Group Limited
APM
|
5.45 M | $ 0.87 | 6.7 % | $ 4.74 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
56.3 M | $ 2.63 | -1.5 % | $ 148 M | China |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | USA |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
2.41 B | $ 3.55 | -0.56 % | $ 8.54 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | USA |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
60.3 M | - | - | $ 1.01 B | USA |
 |
Aptose Biosciences
APTO
|
699 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
54.8 M | $ 221.53 | -0.23 % | $ 5 B |  Danmark |
 |
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | USA |
 |
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | USA |
 |
BioNTech SE
BNTX
|
244 M | $ 112.43 | 1.89 % | $ 27.2 B | Germany |
 |
Cabaletta Bio
CABA
|
1.17 M | $ 2.59 | 5.94 % | $ 3.03 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
60.8 M | - | -6.81 % | $ 3.04 B | USA |
 |
Aridis Pharmaceuticals
ARDS
|
18.8 M | - | 17.91 % | $ 11.1 M | USA |
 |
Burford Capital Limited
BUR
|
219 M | $ 9.29 | 3.45 % | $ 1.45 B | Britain |
 |
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | USA |
 |
Athira Pharma
ATHA
|
38.5 M | - | - | $ 269 M | USA |
 |
Athersys
ATHX
|
224 M | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | USA |
 |
Avenue Therapeutics
ATXI
|
1.3 M | - | -52.27 % | $ 4.45 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.18 B | $ 4.55 | 6.29 % | $ 9.9 B |  Israel |
 |
Autolus Therapeutics plc
AUTL
|
255 M | $ 1.46 | -0.1 % | $ 373 M | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
309 M | $ 14.52 | - | $ 4.49 B | USA |
 |
Codexis
CDXS
|
73.4 M | $ 1.29 | 0.01 % | $ 94.7 M | USA |
 |
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | USA |
 |
AVROBIO
AVRO
|
44.3 M | - | 1083.1 % | $ 745 M | USA |
 |
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | Germany |
 |
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | Israel |